Trilogy Capital’s Kellanova K Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,832
Closed -$214K 319
2023
Q4
$214K Sell
3,832
-5,363
-58% -$280K 0.01% 260
2023
Q3
$514K Buy
9,195
+4,086
+80% +$243K 0.03% 165
2023
Q2
$325K Buy
5,109
+125
+3% +$7.97K 0.02% 219
2023
Q1
$313K Sell
4,984
-27,746
-85% -$1.75M 0.02% 208
2022
Q4
$2.19M Buy
32,730
+4,618
+16% +$313K 0.16% 85
2022
Q3
$1.84M Buy
28,112
+1,283
+5% +$88.2K 0.16% 63
2022
Q2
$1.8M Buy
26,829
+3,573
+15% +$232K 0.16% 57
2022
Q1
$1.41M Buy
+23,256
New +$1.4M 0.1% 84
2019
Q1
Sell
-4,708
Closed -$252K 145
2018
Q4
$252K Sell
4,708
-910
-16% -$54.9K 0.03% 111
2018
Q3
$369K Sell
5,618
-954
-15% -$64.3K 0.05% 106
2018
Q2
$431K Sell
6,572
-916
-12% -$54.5K 0.06% 83
2018
Q1
$457K Buy
+7,488
New +$473K 0.07% 81

Other funds holding K

Trilogy Capital's K Position: Q1 2024 in Review

Trilogy Capital sold out of Kellanova (K) in Q1 2024, closing a stake of 3,832 shares — an estimated $214K sold.

Trilogy Capital first reported a position in K in Q1 2018 and held it in 12 quarters. The position peaked at $2.19M in Q4 2022. 838 funds tracked by Wall St. Rank hold K as of Q1 2024.

  • Trilogy Capital reported no remaining Kellanova position as of Q1 2024 after selling out during the quarter.
  • Trilogy Capital sold 3,832 Kellanova shares in Q1 2024, an estimated $214K.
  • Trilogy Capital first reported a position in Kellanova in Q1 2018 and held it in 12 quarters.
  • Trilogy Capital's Kellanova position peaked at $2.19M in Q4 2022.
  • 838 funds tracked by Wall St. Rank held Kellanova as of Q1 2024.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.